More Bad News for Women with HCM

A recent retrospective study by researchers using data from the SHaRe Registry found that women with hypertrophic cardiomyopathy have an increased risk of death and/or severe heart failure symptoms when compared to their male counterparts.  This study also found that women tended to be older when diagnosed with HCM than men. 

This study echoes a 2017 study from Mayo Clinic with similar findings.

Editor’s Note:  It is clear that serious research into gender differences in HCM is needed. And, it is vitally important that women with HCM be persistent and diligent in obtaining expert care for their HCM. Their lives depend on it!


More is Needed for Women With HCM

A recent study published in the European Heart Journal by doctors from the Mayo Clinic showed that women with hypertrophic cardiomyopathy (HCM) have a statistically reduced rate of survival as compared to men with HCM.

Continue reading “More is Needed for Women With HCM”

More ICD Complications for Women and African-Americans?

According to an article in the Wall Street Journal citing a recent study in the Annals of Internal Medicine, African-Americans with ICDs were 14% more likely to have complications than white patients with implantable defibrillators, and while women with ICDs were 16% more likely to have complications than men with implantable defibrillators.

The sex-based differences were attributed to the fact that women are generally diagnosed with heart disease later than men, and the fact the device testing process largely omits women, while the race-based differences were less clear, but may have resulted from diminished access to health care by African-American patients.